News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
662,541 Results
Type
Article (51320)
Company Profile (448)
Press Release (610756)
Multimedia
Podcasts (157)
Webinars (19)
Section
Business (169575)
Career Advice (3128)
Deals (31553)
Drug Delivery (125)
Drug Development (80640)
Employer Resources (181)
FDA (15677)
Job Trends (13575)
News (303540)
Policy (29696)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2819)
Academic (1)
Accelerated approval (32)
Adcomms (36)
Allergies (143)
Alliances (45238)
ALS (177)
Alzheimer's disease (1733)
Antibody-drug conjugate (ADC) (337)
Approvals (15874)
Artificial intelligence (534)
Autoimmune disease (162)
Automation (35)
Bankruptcy (303)
Best Places to Work (11048)
BIOSECURE Act (21)
Biosimilars (187)
Biotechnology (314)
Bladder cancer (158)
Brain cancer (63)
Breast cancer (652)
Cancer (4912)
Cardiovascular disease (430)
Career advice (2662)
Career pathing (39)
CAR-T (307)
CDC (49)
Celiac Disease (2)
Cell therapy (828)
Cervical cancer (35)
Clinical research (68688)
Collaboration (1761)
Company closure (5)
Compensation (1092)
Complete response letters (69)
COVID-19 (2744)
CRISPR (98)
C-suite (822)
Cystic fibrosis (154)
Data (6240)
Decentralized trials (2)
Denatured (49)
Depression (146)
Diabetes (518)
Diagnostics (6031)
Digital health (42)
Diversity (11)
Diversity, equity & inclusion (46)
Drug discovery (267)
Drug pricing (199)
Drug shortages (33)
Duchenne muscular dystrophy (241)
Earnings (66393)
Editorial (65)
Employer branding (23)
Employer resources (162)
Events (111997)
Executive appointments (943)
FDA (18735)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1500)
Gene editing (214)
Generative AI (48)
Gene therapy (673)
GLP-1 (1047)
Government (4683)
Grass and pollen (8)
Guidances (363)
Healthcare (18645)
HIV (60)
Huntington's disease (48)
IgA nephropathy (85)
Immunology and inflammation (280)
Immuno-oncology (59)
Indications (102)
Infectious disease (3004)
Inflammatory bowel disease (203)
Inflation Reduction Act (17)
Influenza (105)
Intellectual property (244)
Interviews (609)
IPO (15010)
IRA (56)
Job creations (2906)
Job search strategy (2156)
JPM (68)
Kidney cancer (14)
Labor market (80)
Layoffs (546)
Leadership (39)
Legal (6293)
Liver cancer (88)
Longevity (15)
Lung cancer (655)
Lymphoma (377)
Machine learning (41)
Management (64)
Manufacturing (796)
MASH (169)
Medical device (12434)
Medtech (12486)
Mergers & acquisitions (17635)
Metabolic disorders (1338)
Multiple sclerosis (157)
NASH (21)
Neurodegenerative disease (342)
Neuropsychiatric disorders (99)
Neuroscience (3024)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4550)
Now hiring (49)
Obesity (640)
Opinion (327)
Ovarian cancer (166)
Pain (210)
Pancreatic cancer (218)
Parkinson's disease (294)
Partnered (34)
Patents (484)
Patient recruitment (485)
Peanut (57)
People (52014)
Pharmaceutical (80)
Pharmacy benefit managers (30)
Phase 1 (21501)
Phase 2 (30334)
Phase 3 (22674)
Pipeline (5066)
Policy (315)
Postmarket research (2385)
Preclinical (9108)
Press Release (67)
Prostate cancer (249)
Psychedelics (57)
Radiopharmaceuticals (297)
Rare diseases (910)
Real estate (5217)
Recruiting (75)
Regulatory (23174)
Reports (41)
Research institute (2510)
Resumes & cover letters (498)
Rett syndrome (28)
RNA editing (21)
RSV (77)
Schizophrenia (157)
Series A (252)
Series B (194)
Service/supplier (10)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (165)
Sponsored (46)
Startups (3421)
State (2)
Stomach cancer (19)
Supply chain (102)
Tariffs (84)
The Weekly (107)
Vaccines (1012)
Venture capital (96)
Weight loss (430)
Women's health (79)
Worklife (22)
Date
Last 7 days (602)
Last 30 days (2095)
Last 365 days (30096)
2026 (2842)
2025 (30541)
2024 (35114)
2023 (39348)
2022 (49739)
2021 (54086)
2020 (51878)
2019 (44920)
2018 (34073)
2017 (31478)
2016 (30937)
2015 (35602)
2014 (27760)
2013 (22649)
2012 (23854)
2011 (24507)
2010 (22200)
Location
Africa (902)
Alabama (85)
Alaska (6)
Arizona (241)
Arkansas (14)
Asia (39556)
Australia (6930)
California (10933)
Canada (3159)
China (1137)
Colorado (451)
Connecticut (458)
Delaware (325)
Europe (92323)
Florida (1604)
Georgia (356)
Hawaii (3)
Idaho (61)
Illinois (851)
India (65)
Indiana (481)
Iowa (21)
Japan (419)
Kansas (118)
Kentucky (40)
Louisiana (27)
Maine (60)
Maryland (1304)
Massachusetts (8136)
Michigan (302)
Minnesota (602)
Mississippi (4)
Missouri (125)
Montana (32)
Nebraska (22)
Nevada (107)
New Hampshire (76)
New Jersey (2933)
New Mexico (31)
New York (2892)
North Carolina (1457)
North Dakota (9)
Northern California (5302)
Ohio (321)
Oklahoma (21)
Oregon (40)
Pennsylvania (2202)
Puerto Rico (19)
Rhode Island (45)
South America (1185)
South Carolina (62)
Southern California (4266)
Tennessee (136)
Texas (1657)
United States (38966)
Utah (302)
Virginia (253)
Washington D.C. (74)
Washington State (931)
West Virginia (4)
Wisconsin (104)
Wyoming (2)
662,541 Results for "the column group".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing
September 30, 2025
·
3 min read
Press Releases
Trinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances
December 16, 2025
·
6 min read
Press Releases
Swiss Rockets Group and Alloy Therapeutics Partner to Advance Radioligand Therapeutics in Oncology
January 12, 2026
·
3 min read
Press Releases
Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy
February 1, 2026
·
4 min read
Leadership
The Four Employment Agreement Questions Every Pharma Executive Must Ask
Clarity on employment terms is essential to protect careers. In this column, Kaye/Bassman’s Michael Pietrack speaks to employment attorney Howard Matalon, JD, partner at OlenderFeldman, on how to evaluate the fine print of an employment agreement.
December 18, 2025
·
6 min read
·
Michael Pietrack
Deals
NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP
NGM Biopharmaceuticals, Inc. announced that it has entered into a definitive Agreement and Plan of Merger under which Atlas Neon Parent, Inc. and Atlas Neon Merger Sub, Inc. will acquire NGM Bio through a cash tender offer to be commenced by Merger Sub for all outstanding shares of NGM Bio not held by affiliates of The Column Group, LP and certain other stockholders, as described below, at a price per share of $1.55 in cash.
February 26, 2024
·
9 min read
Press Releases
NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions
January 5, 2026
·
9 min read
Press Releases
Secura Bio Announces Participation in Gilmartin Group’s 2026 Corporate Access Event in San Francisco
December 24, 2025
·
4 min read
Press Releases
Theralase(R) Provides Update on Bladder Cancer Clinical Study
Interim clinical data has exceeded the recommended guidelines of the International Bladder Cancer Group for complete response and duration of complete response
February 4, 2026
·
7 min read
Press Releases
Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day
February 3, 2026
·
7 min read
1 of 66,255
Next
